CENES

Serial Number 75981814
601

Registration Progress

Application Filed
Dec 21, 1999
Under Examination
Apr 6, 2004
Approved for Publication
Dec 4, 2002
Published for Opposition
Dec 24, 2002
Registered

Basic Information

Serial Number
75981814
Filing Date
December 21, 1999
Published for Opposition
December 24, 2002
Abandonment Date
February 28, 2003
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Feb 28, 2003
Classes
005 009 042

Rights Holder

CeNeS Limited

03
Address
Compass House
Vision Park, Chivers Way
Histon, Cambridge CB4 4ZR
GB

Ownership History

CeNeS Limited

Original Applicant
03
Histon, Cambridge CB4 4ZR GB

CeNeS Limited

Owner at Publication
03
Histon, Cambridge CB4 4ZR GB

Legal Representation

Attorney
Mark S. Sommers

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description
Apr 6, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 28, 2003 MAIL I PAPER RECEIVED
Feb 28, 2003 ABN1 S ABANDONMENT - EXPRESS MAILED
Feb 4, 2003 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 24, 2002 PUBO A PUBLISHED FOR OPPOSITION
Dec 4, 2002 NPUB O NOTICE OF PUBLICATION
Sep 20, 2002 CNEA O EXAMINERS AMENDMENT MAILED
Sep 20, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2002 CNEA O EXAMINERS AMENDMENT MAILED
Mar 12, 2002 DOCK D ASSIGNED TO EXAMINER
Mar 8, 2002 CNRT O NON-FINAL ACTION MAILED
Jan 31, 2002 DOCK D ASSIGNED TO EXAMINER
Dec 22, 2001 DPCC D DIVISIONAL PROCESSING COMPLETE
Oct 5, 2001 DRRR I DIVISIONAL REQUEST RECEIVED
Oct 5, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2001 CNSL F LETTER OF SUSPENSION MAILED
Nov 29, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2000 CNRT F NON-FINAL ACTION MAILED
May 16, 2000 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
DRUGS FOR THE MANAGEMENT OF PAIN AND RELATED CONDITIONS; PAIN CONTROL DRUGS; DRUGS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND NEUROLOGICAL AND PSYCHIATRIC DISORDERS; DRUGS FOR THE TREATMENT OF COGNITIVE AND MOTOR DISORDERS; DRUGS FOR USE IN CONNECTION WITH DRUG ABUSE; ANALGESICS; AND ION CHANNEL MODULATORS
First Use Anywhere: 0
First Use in Commerce: 0
Class 009
COMPUTER HARDWARE, EXPERIMENTAL APPARATUS AND INSTRUMENTATION, AND COMPUTER SOFTWARE AND HARDWARE FOR COGNITIVE, PSYCHOLOGICAL, AND NEUROPSYCHOLOGICAL TESTING; COGNITION AND NEUROPSYCHOLOGICAL TESTING SYSTEMS EMPLOYING VISUAL TESTS DISPLAYED ON A COMPUTER SCREEN FOR TESTING HUMANS AND ANIMALS COMPOSED OF COMPUTER SOFTWARE AND COMPUTER HARDWARE; SCIENTIFIC AND LABORATORY APPARATUS AND INSTRUMENTS FOR ELECTROPHYSIOLOGICAL TESTING; COMPUTER SOFTWARE FOR CONTROLLING COGNITIVE PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING APPARATUS SCIENTIFIC AND LABORATORY APPARATUS AND INSTRUMENTS FOR ELECTROPHYSIOLOGICAL TESTING, AND OPERANT CHAMBERS FOR ANIMAL TESTING; DATABASE MANAGEMENT SOFTWARE AND ELECTRONIC DATABASES IN THE FIELD OF COGNITIVE, PSYCHOLOGICAL, AND NEUROPSYCHOLOGICAL TESTING RECORDED ON COMPUTER MEDIA; TOUCH SCREEN APPARATUS FOR ALL THE AFORESAID; AND PARTS AND FITTINGS FOR ALL THE AFORESAID
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
BIOTECHNOLOGY RESEARCH AND DEVELOPMENT; NEUROLOGICAL, PHARMACEUTICAL, AND GENETIC RESEARCH AND DEVELOPMENT; DRUG DISCOVERY, DESIGN, AND RESEARCH AND DEVELOPMENT; RESEARCH AND DEVELOPMENT RELATING TO ION CHANNEL MODULATORS, NEURODEGENERACTIVE DISEASES, ANALGESICS, AND PAIN CONTROL; NEUROPSYCHOLOGICAL AND DIAGNOSTIC TESTING, RESEARCH AND DEVELOPMENT; CONSULTANCY SERVICES RELATING TO ALL THE AFORESAID
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 009 042